Top 10 Life Science Angel Investors in Canada (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Balaji Srinivasan
Angel
|
2 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $450k–$28M |
|
James Novak
Angel
|
1 | Canada | Seed | Medical, Health Care, Life Science | |
|
Danny Ardellini
Angel
|
1 | Canada | Seed | Medical, Health Care, Life Science | |
|
Carol Leaman
Angel
|
1 | Canada | Seed, Angel, Series A | Health Care, Medical, Hospital | $3.3M–$4M |
|
Milad Alucozai
Angel
|
1 | United States, Canada, United Kingdom | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $110k–$60M |
|
Rami Essaid
Angel
|
1 | United States, India, Canada | Seed, Pre-Seed | SaaS, FinTech, Software | $32k–$20M |
|
Ethan Oren Perlstein
Angel
|
1 | United States, Canada | Seed | Biotechnology, Life Science, Cannabis | |
|
Jed McCaleb
Angel
|
1 | United States, Canada | Seed, Series A, Initial Coin Offering | Internet, Payments, Space Travel | $1M–$300M |
|
Dan Schultz
Angel
|
1 | Canada, United States | Seed | SaaS, Data Mining, Life Science | $1M–$3M |
|
Joe Betts-Lacroix
Angel
|
1 | United States | Seed | Life Science, Biotechnology, Pharmaceutical | $3.6M–$4.3M |
| Access all 16 angel investors in Canada Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 271
- Round size: Seed $2.3M–$15M; Pre-Seed $450k–$4.2M; Series A $6M–$28M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
- BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
James Novak is based out of Toronto, Ontario, and is the Chief Executive Officer of Element451. James previously worked at Zoovu as a Chief Executive Officer and Board Member. James Novak attended Wilfrid Laurier University.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KeyOps — A revolutionary physician engagement platform that allows doctors to quickly share their expert opinions with healthcare stakeholders such as government institutions, hospitals, universities, and life science companies.
Danny Ardellini is the Founder & CEO at Environmental 360 Solutions
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed
- Geography: Canada
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KeyOps — A revolutionary physician engagement platform that allows doctors to quickly share their expert opinions with healthcare stakeholders such as government institutions, hospitals, universities, and life science companies.
Carol Leaman is based out of Kitchener, Ontario. Carol previously worked at Axonify as a CEO and Co-Founder. Carol Leaman attended the University of Waterloo.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Angel, Series A
- Geography: Canada
Investor stats
- Total investments: 4
- Round size: Seed $3.3M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- KeyOps — A revolutionary physician engagement platform that allows doctors to quickly share their expert opinions with healthcare stakeholders such as government institutions, hospitals, universities, and life science companies.
- Friendlier — Friendlier aims to reduce single-use plastic waste generated by disposable food packaging. We provide businesses with reusable plastic cups and containers, and take care of delivery, pick-up, and washing.
- PragmaClin — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 55
- Round size: Seed $1M–$7M; Pre-Seed $110k–$5M; Series A $13M–$60M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Revalia Bio — Revalia Bio develops curative drugs for chronic organ-centered disease.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Rami Essaid is the Co-Founder and Chief Executive Officer of Finmark, a Venture Partner at IDEA Fund Partners, and an Extended Team Member of Ubiquity Ventures. He was the Co-Founder and Chairman of Distil. Rami helps enterprises embrace the cloud to improve their scalability and reliability while maintaining a high level of security.He attendedNorth Carolina State University where he majored in computer engineering.
Show more...Investment focus
- Industry: SaaS, FinTech, Software
- Stage:Seed, Pre-Seed
- Geography: United States, India, Canada
Investor stats
- Total investments: 6
- Round size: Seed $32k–$20M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Pacto — Pacto is a B2B enterprise software and payments platform focused on small merchants in Latin America. Pacto builds tools and technology to allow banks and financial institutions to empower merchants to move beyond cash payments and accelerate growth in their digital business. Pacto is headquartered in Mexico City, Mexico.
- Henry — Henry is a software company that develops AI-powered workflow automation tools for commercial real estate professionals. Its platform automates underwriting, market research, comparable property analysis, transaction tracking, buyer identification, and pitch deck creation. The platform also builds and maintains proprietary property and transactiondatabases, generates Excel-based underwriting models, and integrates with existing workflows to support investment sales, acquisitions, and brokerage teams throughout the deal process.
- Kontigo — We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app.
Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs anddiscovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Cannabis
- Stage:Seed
- Geography: United States, Canada
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Epinoma — Epinoma is a diagnostics company that focuses on the multi-omics approach to cancer monitoring. It engineers proteins that control the operating system of biology. The company was founded in 2020 and is headquartered in San Francisco, California.
- BluumBio — BluumBio develops next-generation remediation technologies that clean up pollution and restore degraded ecosystems
- Promakhos Therapeutics — A Boston-based biotech startup developing therapeutics.
Jed McCaleb is based out of San Francisco, California and is the Founder of Vast. Jed previously worked at Ripple as a Co-Founder.
Show more...Investment focus
- Industry: Internet, Payments, Space Travel
- Stage:Seed, Series A, Initial Coin Offering
- Geography: United States, Canada
Investor stats
- Total investments: 7
- Round size: Seed $1M–$4.6M; Series A $42M–$300M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vast — Vast designs and develops commercial space stations for long-duration human missions, including concepts that use artificial gravity. The company engineers pressurized modules, habitation systems, power and thermal control, and docking interfaces, and integrates crew transportation via partner launch providers. Programs include Haven-1 and a largermodular station architecture that supports microgravity research, in-space manufacturing, and private astronaut expeditions. VAST SPACE, LLC collaborates with SpaceX for Crew Dragon missions and works with government and industry under collaborative agreements. Capabilities span mission design, payload accommodation, and on-orbit operations to enable sustained human presence in low Earth orbit and beyond.
- AstroForge — We mine asteroids to extract valuable minerals in space at a lower cost and smaller carbon footprint than the current terrestrial mining methods.
- Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
Dan Schultz
Show more...Investment focus
- Industry: SaaS, Data Mining, Life Science
- Stage:Seed
- Geography: Canada, United States
Investor stats
- Total investments: 2
- Round size: Seed $1M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
- Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.
Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: United States
Investor stats
- Total investments: 2
- Round size: Seed $3.6M–$4.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
- Spring Discovery — Giving Scientists AI Superpowers
Life Science Angel investor funding in Canada at a glance
Stats across 13 deals from 16 investors.
Access all 16 angel investors in Canada Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 16 angel investors investing in Canada Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
